Rotman Harris
- SEC CIK
- 0001981420
No open-market purchases or sales filed in the past year.
Current role at each company
- CNTA Centessa Pharmaceuticals plcSVP Regulatory Affairsas of Feb 2, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Rotman Harris as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 2, 2024 (view filing) | Feb 1 | 1 day | Rotman HarrisSVP Regulatory Affairs | SSale | −4.27K | $8.10 | −$34.6K | −6.4%62.6K after | 10b5-1 |
| Sep 22, 2023 (view filing) | Sep 20 | 2 days | Rotman HarrisSVP Regulatory Affairs | SSale | −37.5K | $6.29 | −$235.8K | −52.8%33.5K after | 10b5-1 |